Home/ Stocks/ EOLS

Evolus, Inc. Common Stock

EOLS XNAS

$7.59 +0.16 (+2.16%) ▲ 15-min delayed

Open

$7.28

High

$7.80

Low

$7.21

Volume

1.63M

Market Cap

$489.43M

About Evolus, Inc. Common Stock

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 353 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$84.08M	$-8,052,000	$-0.12
Q1 2026	$73.14M	$-10,674,000	$-0.16
FY 2025	$297.18M	$-51,641,000	$-0.80
Q3 2025	$68.97M	$-15,737,000	$-0.24

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for EOLS yet. Check out our latest market news or earnings calendar.

Get EOLS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Evolus, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.